Graft versus host disease (GVHD) is a condition that can happen after an allogeneic stem cell transplant (also called a bone marrow transplant). In GVHD, immune cells from the donor attack healthy tissues in the patient’s body.
There are 2 kinds of transplants based on the source of the blood-forming stem cells: allogeneic and autologous. An allogeneic transplant occurs when the cells come from another person. An autologous transplant occurs when the cells come from the patient. GVHD occurs when donor immune cells (allogeneic) attack the patient’s normal cells by mistake.
GVHD symptoms depend on which parts of the body are affected, such as the skin, digestive tract, liver, eyes, and mouth. Based on symptoms and when they develop, GVHD may be considered acute GVHD or chronic GVHD.
GVHD can be graded as mild, moderate, or severe. In some cases, GVHD can be life threatening. Your care team will take steps to help lower the risk of GVHD and plan follow-up care based on your child’s needs. Treatments for GVHD can help regulate the immune response, relieve symptoms, and prevent tissue and organ damage.
GVHD can happen after an allogeneic transplant that uses cells from another person, called a donor. The goal of a stem cell transplant is for the donor cells to grow and make healthy blood cells in your child’s body. GVHD occurs when cells from the donor (the graft) recognize your child’s cells and tissues (the host) as different and attack them. This reaction is called graft-versus-host disease (GVHD).
GVHD does not occur after an autologous transplant, which uses a person’s own stem cells.
Acute GVHD most often affects the skin, gastrointestinal (GI) tract, and liver. It often occurs during the first 100 days after transplant, but can occur later.
Signs and symptoms of acute GVHD (aGVHD) often appear and worsen quickly, and may include:
Skin
GI tract
Liver
Chronic GVHD can affect many organs. It is similar to an autoimmune disease because the donor cells continue to attack healthy tissues. Chronic GVHD often develops more than 100 days after transplant, but can happen earlier.
Signs and symptoms of chronic GVHD (cGVHD) often appear and worsen slowly, and may include:
Skin, hair, and nails
Mouth and digestive tract
Eyes
Lungs
Muscles and joints
Liver
Genitals and sexual health
Chronic GVHD can affect the genital area in both females and males. Symptoms may include:
Several factors can affect a person's risk of developing GVHD after an allogeneic stem cell transplant. Risk factors for GVHD include:
Your child's care team considers these factors when choosing a donor and planning treatment.
Your child’s care team will take steps to help prevent GVHD.
Your child’s care team will choose the closest HLA-matched donor available. HLA stands for human leukocyte antigens. HLA are proteins or markers that are on most cells in the body. The immune system uses HLA to recognize which cells belong in your body and which ones don’t.
Each person has a different combination of HLA markers. They are determined by genes, which are inherited, or passed down from parents to children. So, family members may have similar HLA types. Since children inherit one set of HLA markers from each parent, parents are always a half match to their children. Each brother or sister who has the same parents has a 25% chance (1 in 4) of being a close HLA match.
HLA typing is an important first step of testing before an allogeneic stem cell (bone marrow) transplant. The HLA type of your child should match that of the donor as much as possible. If the donor cells are not well-matched to your child's HLA type, your child's cells and the donor cells may attack each other.
Even with a close match, GVHD can still occur.
In some transplants, donor cells are processed to remove or reduce certain immune cells that increase the risk of GVHD.
Your child may receive medicines that help reduce the activity of the donor's immune cells. Medicines to help lower the risk of GVHD may include:
Depending on the transplant plan, the medicines may be given before, during, or after the transplant. Some are given by IV, and others are taken by mouth. Your child may take some medicines for several months. They may need regular blood tests to check medicine levels and help the care team adjust the dose if needed.
Your child will be checked closely for signs of GVHD after transplant. This may include regular physical exams, monitoring symptoms, and lab tests.
Tests may include:
Treatment depends on the type and severity of GVHD and which parts of the body are affected. Chronic GVHD can last months or years and sometimes requires long-term treatment.
Medicines may be given by vein, mouth, cream, ointment, eye drops, or mouth rinse, depending on your child’s symptoms. Treatment with medications often lasts for several months.
Corticosteroids are often used to treat GVHD. Examples include methylprednisolone, dexamethasone, and prednisone. If steroid medicines do not control GVHD, other medicines that target the immune system may be used. Immunosuppressive medications are often used to help train the donor cells to keep them from causing further damage.
Some children may receive a light-based treatment for GVHD, called narrowband UVB phototherapy. It uses a type of ultraviolet light to treat skin problems caused by GVHD. Phototherapy is typically administered by a dermatologist (skin doctor) in close consultation with your transplant doctor.
During extracorporeal photopheresis (ECP), an apheresis machine separates the blood and removes white blood cells. The white blood cells are treated with medicine and ultraviolet light. The white blood cells are returned to your child’s body. The treated white blood cells help change how the immune system responds. This may help reduce the immune attack that causes GVHD.
ECP is typically used when GVHD does not improve with other treatments (refractory GVHD). It requires repeated visits, and patients often need a central line placed to receive ECP.
Extracorporeal photopheresis is a treatment for GVHD that removes white blood cells from the blood and treats them with UV light.
It is not always possible to prevent GVHD. But following the care plan, watching for symptoms, and getting care early can help.
Contact your child's care team right away if your child develops any new symptoms, symptoms that get worse, or symptoms that do not improve.
Also, tell your care team if your child has a fever or other signs of infection, trouble taking medicines, or any changes that concern you.
—
Reviewed: September 2026
Cancer treatment, stem cell transplant, steroid medicines, and other therapies can cause skin side effects. Learn about common skin changes and ways to help prevent and manage them.
GVHD can affect the gastrointestinal tract and cause abdominal pain, nausea and vomiting, and diarrhea. A GVHD diet includes bland foods that are easy for the body to digest. Learn what foods your child should eat and avoid.
Light therapy (photobiomodulation) can decrease pain and swelling in patients with oral mucositis. Learn more about light therapy for mouth and throat sores.